BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20921626)

  • 41. Regulation of the Fanconi anemia pathway by monoubiquitination.
    Gregory RC; Taniguchi T; D'Andrea AD
    Semin Cancer Biol; 2003 Feb; 13(1):77-82. PubMed ID: 12507559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disabling the Fanconi Anemia Pathway in Stem Cells Leads to Radioresistance and Genomic Instability.
    Deng X; Tchieu J; Higginson DS; Hsu KS; Feldman R; Studer L; Shaham S; Powell SN; Fuks Z; Kolesnick R
    Cancer Res; 2021 Jul; 81(13):3706-3716. PubMed ID: 33941615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.
    Martínez S; Pérez L; Galmarini CM; Aracil M; Tercero JC; Gago F; Albella B; Bueren JA
    Br J Pharmacol; 2013 Oct; 170(4):871-82. PubMed ID: 23937566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
    Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
    Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
    Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
    J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging functions of the Fanconi anemia pathway at a glance.
    Sumpter R; Levine B
    J Cell Sci; 2017 Aug; 130(16):2657-2662. PubMed ID: 28811338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M.
    Bakker ST; van de Vrugt HJ; Rooimans MA; Oostra AB; Steltenpool J; Delzenne-Goette E; van der Wal A; van der Valk M; Joenje H; te Riele H; de Winter JP
    Hum Mol Genet; 2009 Sep; 18(18):3484-95. PubMed ID: 19561169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription.
    Schwab RA; Nieminuszczy J; Shah F; Langton J; Lopez Martinez D; Liang CC; Cohn MA; Gibbons RJ; Deans AJ; Niedzwiedz W
    Mol Cell; 2015 Nov; 60(3):351-61. PubMed ID: 26593718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical and functional crosstalk between Fanconi anemia core components and the GINS replication complex.
    Tumini E; Plevani P; Muzi-Falconi M; Marini F
    DNA Repair (Amst); 2011 Feb; 10(2):149-58. PubMed ID: 21109493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia.
    Deans AJ; West SC
    Mol Cell; 2009 Dec; 36(6):943-53. PubMed ID: 20064461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.
    Oppezzo A; Bourseguin J; Renaud E; Pawlikowska P; Rosselli F
    J Clin Invest; 2020 Mar; 130(3):1377-1391. PubMed ID: 31877112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors.
    Moriel-Carretero M; Ovejero S; Gérus-Durand M; Vryzas D; Constantinou A
    J Cell Biol; 2017 Dec; 216(12):4007-4026. PubMed ID: 29030393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ubiquitin family meets the Fanconi anemia proteins.
    Renaudin X; Koch Lerner L; Menck CF; Rosselli F
    Mutat Res Rev Mutat Res; 2016; 769():36-46. PubMed ID: 27543315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target.
    Hucl T; Gallmeier E
    Physiol Res; 2011; 60(3):453-65. PubMed ID: 21401292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Fanconi anemia pathway and ubiquitin.
    Jacquemont C; Taniguchi T
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S10. PubMed ID: 18047734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis.
    Gueiderikh A; Maczkowiak-Chartois F; Rosselli F
    Blood Rev; 2022 Mar; 52():100904. PubMed ID: 34750031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hsp90 and the Fanconi anemia pathway: a molecular link between protein quality control and the DNA damage response.
    Yamashita T; Oda T; Sekimoto T
    Cell Cycle; 2007 Sep; 6(18):2232-5. PubMed ID: 17881891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fancb deficiency impairs hematopoietic stem cell function.
    Du W; Amarachintha S; Erden O; Wilson A; Meetei AR; Andreassen PR; Namekawa SH; Pang Q
    Sci Rep; 2015 Dec; 5():18127. PubMed ID: 26658157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.